Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, ...

A consolidated feed from 35 million instruments provides sophisticated normalized data, streamlining analysis and decisions from front office to operations. And with flexible delivery options ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

The Bank of Japan’s massive program of quantitative easing, begun in 2013 and at its height involving annual purchases of ¥50 ...

Eversource offers attractive upside as current valuation overstates regulatory risks. Click here to find out why ES stock is ...

Financial firms are increasingly taking advantage of the benefits of cloud computing, including scalability, faster development speed and lower fixed upfront costs. Cloud helps empower end users ...

Efficiency is the top priority: Nearly 90% of respondents believe digital transformation will enhance operational efficiency, yet fewer than one-third (28%) say it is broadly supported within their ...

Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia ...

Gresham follows up its win in the Best sell-side reconciliation platform category of last year’s Sell‑Side Technology Awards ...